Medtronic PLC Conversation and Q&A Session with CST Team Transcript
I think we'll go ahead and get started. Hello, everyone. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thank you for joining us today on a Friday for our Medtronic General Manager Call Series. Today marks the third episode in 2021 of the series and the sixth since we initiated these in late 2019. As you know, we have a full pipeline of innovative products and ongoing launches across our businesses. And with these calls, we want to highlight these, the pipeline items, and give you an opportunity to hear from and interact with our presidents and general managers who are leading these businesses.
For today's event, we're pleased to feature our Cranial and Spinal Technologies operating unit, which we call CST. This is in our neuroscience portfolio. I'm going to invite each of our CST leaders to turn on their video one by one in a moment. But for now, I'll introduce them by name and title. So joining me today is Brett Wall, who's the EVP and President of our Neuroscience portfolio. Next is Carlton Weatherby, who's the VP
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |